-
1
-
-
24044536090
-
Recent concepts in non-alcoholic fatty liver disease
-
Adams LA, Angulo P (2005) Recent concepts in non-alcoholic fatty liver disease. Diabet Med 22: 1129-1133. http://dx.doi.org/10.1111/j.1464-5491.2005.01748.x.
-
(2005)
Diabet Med
, vol.22
, pp. 1129-1133
-
-
Adams, L.A.1
Angulo, P.2
-
2
-
-
84879468929
-
Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease
-
Alisi A, Ceccarelli S, Panera N, Prono F, Petrini S, De Stefanis C, Pezzullo M, Tozzi A, Villani A, Bedogni G, Nobili V (2013) Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease. PLoS One 8: e67160. http://dx.doi.org/10.1371/journal.pone.0067160.
-
(2013)
PLoS One
, vol.8
-
-
Alisi, A.1
Ceccarelli, S.2
Panera, N.3
Prono, F.4
Petrini, S.5
De Stefanis, C.6
Pezzullo, M.7
Tozzi, A.8
Villani, A.9
Bedogni, G.10
Nobili, V.11
-
3
-
-
0024340523
-
Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity
-
Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, Le Cam A (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58: 631-640. http://dx.doi. org/10.1016/0092-8674(89)90098-6.
-
(1989)
Cell
, vol.58
, pp. 631-640
-
-
Auberger, P.1
Falquerho, L.2
Contreres, J.O.3
Pages, G.4
Le Cam, G.5
Rossi, B.6
Le Cam, A.7
-
4
-
-
34249711964
-
Hepatic fibroblast growth factor 21 is regulated by PPAR alpha and is a key mediator of hepatic lipid metabolism in ketotic states
-
Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E (2007) Hepatic fibroblast growth factor 21 is regulated by PPAR alpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5: 426-437. http://dx.doi.org/10.1016/j. cmet.2007.05.002.
-
(2007)
Cell Metab
, vol.5
, pp. 426-437
-
-
Badman, M.K.1
Pissios, P.2
Kennedy, A.R.3
Koukos, G.4
Flier, J.S.5
Maratos-Flier, E.6
-
5
-
-
0025251140
-
Localisation of the human sex hormone-binding globulin gene (SHGB) to the short arm of chromosome 17 (17p12-13)
-
Berube D, Seralini GE, Gagne R, Hammond GL (1990) Localisation of the human sex hormone-binding globulin gene (SHGB) to the short arm of chromosome 17 (17p12-13). Cytogenet Cell Genet 54: 65-67.
-
(1990)
Cytogenet Cell Genet
, vol.54
, pp. 65-67
-
-
Berube, D.1
Seralini, G.E.2
Gagne, R.3
Hammond, G.L.4
-
6
-
-
84884860377
-
Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes
-
Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59: 713-723. http://dx.doi.org/10.1002/hep.26672.
-
(2014)
Hepatology
, vol.59
, pp. 713-723
-
-
Birkenfeld, A.L.1
Shulman, G.I.2
-
7
-
-
84883491952
-
Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features
-
Bonnet F, Valayoudom Cephise FL, Gautier A, Dubois S, Massart C, Camara A, Larifla L, Balkau B, Ducluzeau PH (2013) Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features. Clin Endocrinol (Oxf) 79: 517-522. http://dx.doi.org/10.1111/cen.12089.
-
(2013)
Clin Endocrinol (Oxf)
, vol.79
, pp. 517-522
-
-
Bonnet, F.1
Valayoudom Cephise, F.L.2
Gautier, A.3
Dubois, S.4
Massart, C.5
Camara, A.6
Larifla, L.7
Balkau, B.8
Ducluzeau, P.H.9
-
8
-
-
23944498579
-
Selenoprotein P: an extracellular protein with unique physical characteristic and a role in selenium homeostasis
-
Burk RF, Hill KE (2005) Selenoprotein P: an extracellular protein with unique physical characteristic and a role in selenium homeostasis. Annu Rev Nutr 25: 215-235. http://dx.doi.org/10.1146/annurev. nutr.24.012003.132120.
-
(2005)
Annu Rev Nutr
, vol.25
, pp. 215-235
-
-
Burk, R.F.1
Hill, K.E.2
-
9
-
-
2442545703
-
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
-
Burke A, Lucey MR (2004) Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 4: 686-693. http://dx.doi.org/10.1111/j.1600-6143.2004.00432.x.
-
(2004)
Am J Transplant
, vol.4
, pp. 686-693
-
-
Burke, A.1
Lucey, M.R.2
-
10
-
-
77952558012
-
The natural history of non-alcoholic fatty liver disease
-
Caldwell S, Argo C (2010) The natural history of non-alcoholic fatty liver disease. Dig Dis 28: 162-168. http://dx.doi. org/10.1159/000282081.
-
(2010)
Dig Dis
, vol.28
, pp. 162-168
-
-
Caldwell, S.1
Argo, C.2
-
11
-
-
80053389113
-
Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice
-
Chartoumekis DV, Ziros PG, Psyrogiannis AI, Papavassiliou AG, Kyriazopoulou VE, Sykiotis GP, Habeos IG (2011) Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 60: 2465-2473. http://dx.doi.org/10.2337/db11-0112.
-
(2011)
Diabetes
, vol.60
, pp. 2465-2473
-
-
Chartoumekis, D.V.1
Ziros, P.G.2
Psyrogiannis, A.I.3
Papavassiliou, A.G.4
Kyriazopoulou, V.E.5
Sykiotis, G.P.6
Habeos, I.G.7
-
12
-
-
84874952628
-
Increased selenoprotein P levels in subjects with visceral obesity and nonalcoholic fatty liver disease
-
Choi HY, Hwang SY, Lee CH, Hong HC, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi K (2013) Increased selenoprotein P levels in subjects with visceral obesity and nonalcoholic fatty liver disease. Diabetes Metab J 37: 63-71. http://dx.doi. org/10.4093/dmj.2013.37.1.63.
-
(2013)
Diabetes Metab J
, vol.37
, pp. 63-71
-
-
Choi, H.Y.1
Hwang, S.Y.2
Lee, C.H.3
Hong, H.C.4
Yang, S.J.5
Yoo, H.J.6
Seo, J.A.7
Kim, S.G.8
Kim, N.H.9
Baik, S.H.10
Choi, D.S.11
Choi, K.12
-
13
-
-
57349098220
-
Fibroblast growth factor 21 corrects obesity in mice
-
Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A (2008) Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149: 6018-6027. http://dx.doi. org/10.1210/en.2008-0816.
-
(2008)
Endocrinology
, vol.149
, pp. 6018-6027
-
-
Coskun, T.1
Bina, H.A.2
Schneider, M.A.3
Dunbar, J.D.4
Hu, C.C.5
Chen, Y.6
Moller, D.E.7
Kharitonenkov, A.8
-
14
-
-
77955069684
-
NF-kB mediates lipid-induced fetuin-A expression in hepatocytes that impaires adipocyte function effecting insulin resistance
-
Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, Bhatta-Charya S (2010) NF-kB mediates lipid-induced fetuin-A expression in hepatocytes that impaires adipocyte function effecting insulin resistance. Biochem J 429: 451-462. http://dx.doi. org/10.1042/BJ20100330.
-
(2010)
Biochem J
, vol.429
, pp. 451-462
-
-
Dasgupta, S.1
Bhattacharya, S.2
Biswas, A.3
Majumdar, S.S.4
Mukhopadhyay, S.5
Ray, S.6
Bhatta-Charya, S.7
-
15
-
-
0344393623
-
Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A
-
Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W (2003) Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 376: 135-145. http://dx.doi.org/10.1042/BJ20030676.
-
(2003)
Biochem J
, vol.376
, pp. 135-145
-
-
Denecke, B.1
Graber, S.2
Schafer, C.3
Heiss, A.4
Woltje, M.5
Jahnen-Dechent, W.6
-
16
-
-
84865422329
-
TNF-a represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway
-
Diaz-Delfin J, Hondares E, Iglesias R, Giralt M, Caelles C, Villarroya F (2012) TNF-a represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology 153: 4238-4245. http://dx.doi.org/10.1210/en.2012-1193.
-
(2012)
Endocrinology
, vol.153
, pp. 4238-4245
-
-
Diaz-Delfin, J.1
Hondares, E.2
Iglesias, R.3
Giralt, M.4
Caelles, C.5
Villarroya, F.6
-
17
-
-
84873533674
-
Plasma fetuin A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease
-
Dogru T, Genc H, Tapan S, Aslan F, Ercin CN, Ors F, Kara M, Sertoglu E, Karslioglu Y, Bagci S, Kurt I, Sonmez A (2013) Plasma fetuin A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 78: 712-717. http://dx.doi.org/10.1111/j.1365-2265.2012.04460.x.
-
(2013)
Clin Endocrinol (Oxf)
, vol.78
, pp. 712-717
-
-
Dogru, T.1
Genc, H.2
Tapan, S.3
Aslan, F.4
Ercin, C.N.5
Ors, F.6
Kara, M.7
Sertoglu, E.8
Karslioglu, Y.9
Bagci, S.10
Kurt, I.11
Sonmez, A.12
-
18
-
-
84880198084
-
Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment
-
Dongiovanni P, Anstee QM, Valenti L (2013) Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr Pharm Des 19: 5219-5238. http://dx.doi. org/10.2174/13816128113199990381.
-
(2013)
Curr Pharm Des
, vol.19
, pp. 5219-5238
-
-
Dongiovanni, P.1
Anstee, Q.M.2
Valenti, L.3
-
19
-
-
77955474305
-
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
-
Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Badman MK, Martinez-Chantar ML, Maratos-Flier E (2010) Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology 139: 456-463. http://dx.doi. org/10.1053/j.gastro.2010.04.054.
-
(2010)
Gastroenterology
, vol.139
, pp. 456-463
-
-
Dushay, J.1
Chui, P.C.2
Gopalakrishnan, G.S.3
Varela-Rey, M.4
Crawley, M.5
Fisher, F.M.6
Badman, M.K.7
Martinez-Chantar, M.L.8
Maratos-Flier, E.9
-
20
-
-
62349113882
-
Serum levels of angiopoietin-relatef growth factor in diabetes mellitus and chronic hemodialysis
-
Ebert T, Bachmann A, Losser U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009) Serum levels of angiopoietin-relatef growth factor in diabetes mellitus and chronic hemodialysis. Metabolism 58: 547-551. http://dx.doi.org/10.1016/j.metabol.2008.11.016.
-
(2009)
Metabolism
, vol.58
, pp. 547-551
-
-
Ebert, T.1
Bachmann, A.2
Losser, U.3
Kratzsch, J.4
Bluher, M.5
Stumvoll, M.6
Fasshauer, M.7
-
21
-
-
84928884625
-
Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors
-
Ebert T, Kralish S, Loessner U, Jessnitzer B, Stumvoll M, Fasshauer N, Tonjes A (2014) Relationship between serum levels of angiopoietin-related growth factor and metabolic risk factors. Horm Metab Res 46: 685-690. http://dx.doi.org/10.1055/s-0034-1382078.
-
(2014)
Horm Metab Res
, vol.46
, pp. 685-690
-
-
Ebert, T.1
Kralish, S.2
Loessner, U.3
Jessnitzer, B.4
Stumvoll, M.5
Fasshauer, N.6
Tonjes, A.7
-
22
-
-
79953185045
-
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the ab sence of apparent cirrhosis
-
Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn WK, Canbay A (2011) Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the ab sence of apparent cirrhosis. Int J Cancer 128: 2436-2443. http://dx. doi.org/10.1002/ijc.25797.
-
(2011)
Int J Cancer
, vol.128
, pp. 2436-2443
-
-
Ertle, J.1
Dechene, A.2
Sowa, J.P.3
Penndorf, V.4
Herzer, K.5
Kaiser, G.6
Schlaak, J.F.7
Gerken, G.8
Syn, W.K.9
Canbay, A.10
-
23
-
-
84908291960
-
Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets
-
Fisher FM, Chui PC, Nasser IA, Popov Y, Cunniff JC, Lundasen T, Kharitonenkov A, Schuppan D, Flier JS, Maratos-Flier E (2014) Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 147: 1073-1083. http://dx.doi.org/10.1053/j. gastro.2014.07.044.
-
(2014)
Gastroenterology
, vol.147
, pp. 1073-1083
-
-
Fisher, F.M.1
Chui, P.C.2
Nasser, I.A.3
Popov, Y.4
Cunniff, J.C.5
Lundasen, T.6
Kharitonenkov, A.7
Schuppan, D.8
Flier, J.S.9
Maratos-Flier, E.10
-
24
-
-
84870159894
-
Modulating fibroblast growth factor 21 in hyperphagic OLATF rats with daily exercise and caloric restriction
-
Fletcher JA, Meers GM, Laughlin GM, Ibdah JA, Thyfault JP, Rector RS (2012) Modulating fibroblast growth factor 21 in hyperphagic OLATF rats with daily exercise and caloric restriction. Appl Physiol Nutr Metab 37: 1054-1062. http://dx.doi.org/10.1139/h2012-091.
-
(2012)
Appl Physiol Nutr Metab
, vol.37
, pp. 1054-1062
-
-
Fletcher, J.A.1
Meers, G.M.2
Laughlin, G.M.3
Ibdah, J.A.4
Thyfault, J.P.5
Rector, R.S.6
-
25
-
-
84899472055
-
Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjects
-
Fletcher-Mors M, Schick A, Oeztuerk S, Haenle MM, Wilhelm M, Koenig W, Inhof A, Boehm BO, Graeter T, Mason RA, Kratzer W, Akinli AS, EMIL-Study Group (2014) Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjects. Horm Metab Res 46: 287-293. http://dx.doi.org/10.1055/s-0033-1354369.
-
(2014)
Horm Metab Res
, vol.46
, pp. 287-293
-
-
Fletcher-Mors, M.1
Schick, A.2
Oeztuerk, S.3
Haenle, M.M.4
Wilhelm, M.5
Koenig, W.6
Inhof, A.7
Boehm, B.O.8
Graeter, T.9
Mason, R.A.10
Kratzer, W.11
Akinli, A.S.12
-
26
-
-
77957376253
-
Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse
-
Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuroo M, Mangelsdorl DJ, Kliwer SA (2010) Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24: 2050-2064. http://dx.doi.org/10.1210/me.2010-0142.
-
(2010)
Mol Endocrinol
, vol.24
, pp. 2050-2064
-
-
Fon Tacer, K.1
Bookout, A.L.2
Ding, X.3
Kurosu, H.4
John, G.B.5
Wang, L.6
Goetz, R.7
Mohammadi, M.8
Kuroo, M.9
Mangelsdorl, D.J.10
Kliwer, S.A.11
-
27
-
-
84883481988
-
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
-
Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL, Kharitonenkov A, Bumol T, Schilske HK, Moller DE (2013) The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 18: 333-340. http://dx.doi.org/10.1016/j. cmet.2013.08.005.
-
(2013)
Cell Metab
, vol.18
, pp. 333-340
-
-
Gaich, G.1
Chien, J.Y.2
Fu, H.3
Glass, L.C.4
Deeg, M.A.5
Holland, W.L.6
Kharitonenkov, A.7
Bumol, T.8
Schilske, H.K.9
Moller, D.E.10
-
28
-
-
84867732521
-
Nonalcoholic fatty liver disease and atherosclerosis
-
Gaudio E, Nobili V, Franchitto A, Onori P, Carpino G (2012) Nonalcoholic fatty liver disease and atherosclerosis. Intern Emerg Med 7(suppl 3): 297-305. http://dx.doi.org/10.1007/s11739-012-0826-5.
-
(2012)
Intern Emerg Med
, vol.7
, pp. 297-305
-
-
Gaudio, E.1
Nobili, V.2
Franchitto, A.3
Onori, P.4
Carpino, G.5
-
29
-
-
84879938853
-
Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage
-
Giannini C, Feldstein AE, Santoro N, Kim G, Kursawe R, Pierpont B, Caprio S (2013) Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. J Clin Endocrinol Metab 98: 2993-3000. http://dx.doi.org/10.1210/jc.2013-1250.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 2993-3000
-
-
Giannini, C.1
Feldstein, A.E.2
Santoro, N.3
Kim, G.4
Kursawe, R.5
Pierpont, B.6
Caprio, S.7
-
30
-
-
84857926081
-
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
-
Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Loberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2012) Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 166: 503-510. http://dx.doi.org/10.1530/EJE-11-0864.
-
(2012)
Eur J Endocrinol
, vol.166
, pp. 503-510
-
-
Haukeland, J.W.1
Dahl, T.B.2
Yndestad, A.3
Gladhaug, I.P.4
Loberg, E.M.5
Haaland, T.6
Konopski, Z.7
Wium, C.8
Aasheim, E.T.9
Johansen, O.E.10
Aukrust, P.11
Halvorsen, B.12
Birkeland, K.I.13
-
31
-
-
70350662659
-
Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial
-
Haukeland JW, Konopski Z, Eggesbo HB, von Volkmann HL, Raschpichler G, Bjoro K, Haaland T, Loberg EM, Birkeland K (2009) Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol 44: 853-860. http://dx.doi.org/10.1080/00365520902845268.
-
(2009)
Scand J Gastroenterol
, vol.44
, pp. 853-860
-
-
Haukeland, J.W.1
Konopski, Z.2
Eggesbo, H.B.3
von Volkmann, H.L.4
Raschpichler, G.5
Bjoro, K.6
Haaland, T.7
Loberg, E.M.8
Birkeland, K.9
-
32
-
-
84864696458
-
Fetuin-A: the missing link in lipid-induced inflammation
-
Heinrichsdorff J, Olessky JM (2012) Fetuin-A: the missing link in lipid-induced inflammation. Nat Med 18: 1182-1183. http://dx.doi. org/10.1038/nm.2869.
-
(2012)
Nat Med
, vol.18
, pp. 1182-1183
-
-
Heinrichsdorff, J.1
Olessky, J.M.2
-
33
-
-
84864246433
-
Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience
-
Heuer M, Kaiser GM, Kahraman A, Banysch M, Saner FH, Mathe Z, Gerken G, Paul A, Canbay A, Treckmann JW (2012) Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience. Digestion 86: 107-113. http://dx.doi.org/10.1159/000339344.
-
(2012)
Digestion
, vol.86
, pp. 107-113
-
-
Heuer, M.1
Kaiser, G.M.2
Kahraman, A.3
Banysch, M.4
Saner, F.H.5
Mathe, Z.6
Gerken, G.7
Paul, A.8
Canbay, A.9
Treckmann, J.W.10
-
34
-
-
0030587491
-
Human selenoprotein P gene maps to 5q31
-
Hill KE, Dasouki M, Philips JA 3rd, Burk RF (1996) Human selenoprotein P gene maps to 5q31. Genomics 36: 550-551. http://dx.doi. org/10.1006/geno.1996.0505.
-
(1996)
Genomics
, vol.36
, pp. 550-551
-
-
Hill, K.E.1
Dasouki, M.2
Philips, J.A.3
Burk, R.F.4
-
35
-
-
84899586662
-
Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients
-
Hua X, Sun Y, Zhong Y, Feng W, Huang H, Wang W, Zhang T, Hu Y (2014) Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Clin Endocrinol (Oxf) 80: 877-883. http://dx.doi.org/10.1111/cen.12360.
-
(2014)
Clin Endocrinol (Oxf)
, vol.80
, pp. 877-883
-
-
Hua, X.1
Sun, Y.2
Zhong, Y.3
Feng, W.4
Huang, H.5
Wang, W.6
Zhang, T.7
Hu, Y.8
-
36
-
-
84884210651
-
Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: role of adipokines
-
Hui E, Xu A, Yang HB, Lam KSL (2013) Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: role of adipokines. J Diabetes Investig 4: 413-425. http://dx.doi.org/10.1111/jdi.12093.
-
(2013)
J Diabetes Investig
, vol.4
, pp. 413-425
-
-
Hui, E.1
Xu, A.2
Yang, H.B.3
Lam, K.S.L.4
-
37
-
-
84908200877
-
Fibroblast growth factor 21 is regulated by the IREa-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis
-
Jiang S, Yan C, Fang QC, Shao ML, Zhang YL, Liu Y, Deng YP, Shan B, Liu JQ, Li HT, Yang L, Zhou J, Dai Z, Liu Y, Jia WP (2014) Fibroblast growth factor 21 is regulated by the IREa-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis. J Biol Chem 289: 29751-29765. http://dx.doi.org/10.1074/jbc.M114.565960.
-
(2014)
J Biol Chem
, vol.289
, pp. 29751-29765
-
-
Jiang, S.1
Yan, C.2
Fang, Q.C.3
Shao, M.L.4
Zhang, Y.L.5
Liu, Y.6
Deng, Y.P.7
Shan, B.8
Liu, J.Q.9
Li, H.T.10
Yang, L.11
Zhou, J.12
Dai, Z.13
Liu, Y.14
Jia, W.P.15
-
38
-
-
84910100321
-
The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in Chinese population with normal glucose tolerance
-
Jiang S, Zhang R, Li H, Fang Q, Jiang F, Hou X, Hu C, Jia W (2014) The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in Chinese population with normal glucose tolerance. J Nutrigenet Nutrigenomics 7: 121-129. http://dx.doi.org/10.1159/000367943.
-
(2014)
J Nutrigenet Nutrigenomics
, vol.7
, pp. 121-129
-
-
Jiang, S.1
Zhang, R.2
Li, H.3
Fang, Q.4
Jiang, F.5
Hou, X.6
Hu, C.7
Jia, W.8
-
39
-
-
79751508907
-
Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases
-
Kadamatsu T, Tabata M, Oike Y (2011) Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS J 278: 559-564. http://dx.doi.org/10.1111/j.1742-4658.2010.07979.x.
-
(2011)
FEBS J
, vol.278
, pp. 559-564
-
-
Kadamatsu, T.1
Tabata, M.2
Oike, Y.3
-
40
-
-
84880171111
-
Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
-
Kahraman A, Sowa JP, Schlattjan M, Sydor S, Pronadl M, Wree A, Beilfuss A, Kilicarslan A, Altinbas A, Bechmann LP, Syn WK, Gerken G, Canbay A (2013) Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. Clin Sci (Lond) 125: 391-400. http://dx.doi.org/10.1042/CS20120542.
-
(2013)
Clin Sci (Lond)
, vol.125
, pp. 391-400
-
-
Kahraman, A.1
Sowa, J.P.2
Schlattjan, M.3
Sydor, S.4
Pronadl, M.5
Wree, A.6
Beilfuss, A.7
Kilicarslan, A.8
Altinbas, A.9
Bechmann, L.P.10
Syn, W.K.11
Gerken, G.12
Canbay, A.13
-
41
-
-
70350550096
-
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
-
Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Konigsrainer I, Konigsrainer A, Schick F, Fritsche A, Haring H-U, Stefan N (2009) Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58: 2616-2623. http://dx.doi.org/10.2337/db09-0279.
-
(2009)
Diabetes
, vol.58
, pp. 2616-2623
-
-
Kantartzis, K.1
Peter, A.2
Machicao, F.3
Machann, J.4
Wagner, S.5
Konigsrainer, I.6
Konigsrainer, A.7
Schick, F.8
Fritsche, A.9
Haring, H.-U.10
Stefan, N.11
-
42
-
-
84879405006
-
Liver fat and SHBG affect insulin resistance in midlife women: the study of women's health across the nation (SWAN)
-
Kavanagh K, Espeland MA, Sutton-Tyrrell K, Barinas-Mitchell E, El Khoudary SR, Wildman RP (2013) Liver fat and SHBG affect insulin resistance in midlife women: the study of women's health across the nation (SWAN). Obesity (Silver Spring) 21: 1031-1038. http://dx. doi.org/10.1002/oby.20077.
-
(2013)
Obesity (Silver Spring)
, vol.21
, pp. 1031-1038
-
-
Kavanagh, K.1
Espeland, M.A.2
Sutton-Tyrrell, K.3
Barinas-Mitchell, E.4
El Khoudary, S.R.5
Wildman, R.P.6
-
43
-
-
0019757020
-
Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line
-
Khan MS, Knowles BB, Aden DP, Rosner W (1981) Secretion of testosterone-estradiol-binding globulin by a human hepatoma-derived cell line. J Clin Endocrinol Metab 53: 448-449. http://dx.doi. org/10.1210/jcem-53-2-448.
-
(1981)
J Clin Endocrinol Metab
, vol.53
, pp. 448-449
-
-
Khan, M.S.1
Knowles, B.B.2
Aden, D.P.3
Rosner, W.4
-
44
-
-
84874903440
-
Rational design of a fibroblast growth factor 21-based clinical candidate LY2405319
-
Kharitonenkov A, Beals JM, Micanovic R, Stifler BA, Rathnachalam R, Wroblewski VJ, Li S, Koester A, Ford AM, Coskun T, Dunbar JD, Cheng CC, Frye CC, Bumol TF, Moller DE (2013) Rational design of a fibroblast growth factor 21-based clinical candidate LY2405319. PLoS One 8: e58575. http://dx.doi.org/10.1371/journal. pone.0058575.
-
(2013)
PLoS One
, vol.8
-
-
Kharitonenkov, A.1
Beals, J.M.2
Micanovic, R.3
Stifler, B.A.4
Rathnachalam, R.5
Wroblewski, V.J.6
Li, S.7
Koester, A.8
Ford, A.M.9
Coskun, T.10
Dunbar, J.D.11
Cheng, C.C.12
Frye, C.C.13
Bumol, T.F.14
Moller, D.E.15
-
45
-
-
84925513492
-
Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress
-
Kim SH, Kim KH, Kim H-K, Kim M-J, Back SH, Konishi M, Itoh N, Lee M-S (2015) Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia 58: 809-818. http://dx.doi. org/10.1007/s00125-014-3475-6.
-
(2015)
Diabetologia
, vol.58
, pp. 809-818
-
-
Kim, S.H.1
Kim, K.H.2
Kim, H.-K.3
Kim, M.-J.4
Back, S.H.5
Konishi, M.6
Itoh, N.7
Lee, M.-S.8
-
46
-
-
36348964879
-
Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/Forkhead box class 01-dependent pathway in hepatocytes
-
Kitazawa M, Ohizumi Y, Oike Y, Hishinua T, Hashimoto S (2007) Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt/Forkhead box class 01-dependent pathway in hepatocytes. J Pharmacol Exp Ther 323: 787-793. http://dx.doi.org/10.1124/jpet.107.127530.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 787-793
-
-
Kitazawa, M.1
Ohizumi, Y.2
Oike, Y.3
Hishinua, T.4
Hashimoto, S.5
-
47
-
-
80053627289
-
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
-
Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J, Petersen KF, Samuel VT, Shulman G (2011) Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 108: 16381-16385. http://dx.doi.org/10.1073/pnas.1113359108.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 16381-16385
-
-
Kumashiro, N.1
Erion, D.M.2
Zhang, D.3
Kahn, M.4
Beddow, S.A.5
Chu, X.6
Still, C.D.7
Gerhard, G.S.8
Han, X.9
Dziura, J.10
Petersen, K.F.11
Samuel, V.T.12
Shulman, G.13
-
48
-
-
84899124006
-
LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resitance
-
Lan F, Misu H, Chikamoto K, Takayama H, Kikuchi A, Mohri K, Takata N, Hayashi H, Mutsazawa-Nagata N, Takeshita Y, Noda H, Matsumoto Y, Ota T, nagano T, Nakagen M, Miayamoto K, Takatsuki K, Seo T, Iwayama K, Tokuyama K, Matsugo S, Tang H, Saito Y, Yamoagoe S, Kaneko S, Takamura T (2014) LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resitance. Diabetes 63: 1649-1664. http://dx.doi.org/10.2337/db13-0728.
-
(2014)
Diabetes
, vol.63
, pp. 1649-1664
-
-
Lan, F.1
Misu, H.2
Chikamoto, K.3
Takayama, H.4
Kikuchi, A.5
Mohri, K.6
Takata, N.7
Hayashi, H.8
Mutsazawa-Nagata, N.9
Takeshita, Y.10
Noda, H.11
Matsumoto, Y.12
Ota, T.13
Nagano, T.14
Nakagen, M.15
Miayamoto, K.16
Takatsuki, K.17
Seo, T.18
Iwayama, K.19
Tokuyama, K.20
Matsugo, S.21
Tang, H.22
Saito, Y.23
Yamoagoe, S.24
Kaneko, S.25
Takamura, T.26
more..
-
49
-
-
84939564435
-
Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis
-
Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P, Vaidya D (2015) Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clin Gastroenterol Hepatol 13: 1686-1693. http://dx.doi.org/10.1016/j.cgh.2014.12.033.
-
(2015)
Clin Gastroenterol Hepatol
, vol.13
, pp. 1686-1693
-
-
Lazo, M.1
Zeb, I.2
Nasir, K.3
Tracy, R.P.4
Budoff, M.J.5
Ouyang, P.6
Vaidya, D.7
-
50
-
-
84907638181
-
Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease
-
Lebensztejn DM, Bialokoz-Kalinowska I, Klusek-Oksiuta M, Tarasow E, Wojtkowska M, Kaczmarski M (2014) Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. Adv Med Sci 59: 81-84. http://dx.doi.org/10.1016/j.advms.2013.08.003.
-
(2014)
Adv Med Sci
, vol.59
, pp. 81-84
-
-
Lebensztejn, D.M.1
Bialokoz-Kalinowska, I.2
Klusek-Oksiuta, M.3
Tarasow, E.4
Wojtkowska, M.5
Kaczmarski, M.6
-
51
-
-
84990217563
-
Fibroblast growth factor 21 concentration in obese children with nonalcoholic fatty liver disease
-
(abstract).
-
Lebensztejn DM, Wasilewska N, Bobrus-Chociej A, Werpachowska I, Tarasow E (2016) Fibroblast growth factor 21 concentration in obese children with nonalcoholic fatty liver disease. Hepatol Int 10(suppl 1): 398-399 (abstract).
-
(2016)
Hepatol Int
, vol.10
, pp. 398-399
-
-
Lebensztejn, D.M.1
Wasilewska, N.2
Bobrus-Chociej, A.3
Werpachowska, I.4
Tarasow, E.5
-
52
-
-
84904399681
-
Exendin-4 regulates lipid metabolism and fibroblast growth factor-21 in hepatic steatosis
-
Lee J, Hong SW, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Lee WY (2014) Exendin-4 regulates lipid metabolism and fibroblast growth factor-21 in hepatic steatosis. Metabolism 63: 1041-1048. http://dx.doi.org/10.1016/j.metabol.2014.04.011.
-
(2014)
Metabolism
, vol.63
, pp. 1041-1048
-
-
Lee, J.1
Hong, S.W.2
Park, S.E.3
Rhee, E.J.4
Park, C.Y.5
Oh, K.W.6
Park, S.W.7
Lee, W.Y.8
-
53
-
-
84874117479
-
High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China
-
Li H, Dong K, Fang Q, Hou X, Zhou M, Bao Y, Xiang K, Xu A, Jia W (2013) High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China. J Hepatol 58: 557-563. http://dx.doi. org/10.1016/j.jhep.2012.10.029.
-
(2013)
J Hepatol
, vol.58
, pp. 557-563
-
-
Li, H.1
Dong, K.2
Fang, Q.3
Hou, X.4
Zhou, M.5
Bao, Y.6
Xiang, K.7
Xu, A.8
Jia, W.9
-
54
-
-
77957359658
-
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
-
Li H, Fang Q, Gao F, Fan J, Zjou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W (2010) Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 53: 934-940. http://dx.doi.org/10.1016/j.jhep.2010.05.018.
-
(2010)
J Hepatol
, vol.53
, pp. 934-940
-
-
Li, H.1
Fang, Q.2
Gao, F.3
Fan, J.4
Zjou, J.5
Wang, X.6
Zhang, H.7
Pan, X.8
Bao, Y.9
Xiang, K.10
Xu, A.11
Jia, W.12
-
55
-
-
84874800718
-
Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
-
Li H, Zhang J, Jia W (2013) Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology. Front Med 7: 25-30. http://dx.doi.org/10.1007/s11684-013-0244-8.
-
(2013)
Front Med
, vol.7
, pp. 25-30
-
-
Li, H.1
Zhang, J.2
Jia, W.3
-
56
-
-
80755189417
-
The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose-lipid metabolism in vitro
-
Li K, Li L, Yang M, Liu H, Boden G, Yang G (2012) The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose-lipid metabolism in vitro. Mol Cell Endocrinol 348: 21-26. http://dx.doi.org/10.1016/j.mce.2011.07.026.
-
(2012)
Mol Cell Endocrinol
, vol.348
, pp. 21-26
-
-
Li, K.1
Li, L.2
Yang, M.3
Liu, H.4
Boden, G.5
Yang, G.6
-
57
-
-
84921771693
-
The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy
-
Liu J, Xu Y, Hu Y, Wang G (2015) The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 64: 380-390. http://dx.doi. org/10.1016/j.metabol.2014.11.009.
-
(2015)
Metabolism
, vol.64
, pp. 380-390
-
-
Liu, J.1
Xu, Y.2
Hu, Y.3
Wang, G.4
-
58
-
-
84885230287
-
Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease
-
Malin SK, Mulya A, Fealy CE, Haus JM, Pagadala MR, Scelsi AR, Huang H, Flask CA, McCullough AJ, Kirwan JP (2013) Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. J Appl Physiol 115: 988-994. http://dx.doi.org/10.1152/japplphysiol.00237.2013.
-
(2013)
J Appl Physiol
, vol.115
, pp. 988-994
-
-
Malin, S.K.1
Mulya, A.2
Fealy, C.E.3
Haus, J.M.4
Pagadala, M.R.5
Scelsi, A.R.6
Huang, H.7
Flask, C.A.8
McCullough, A.J.9
Kirwan, J.P.10
-
59
-
-
0036328567
-
Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene
-
Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G (2002) Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51: 2450-2458. http://dx.doi. org/10.2337/diabetes.51.8.2450.
-
(2002)
Diabetes
, vol.51
, pp. 2450-2458
-
-
Mathews, S.T.1
Singh, G.P.2
Ranalletta, M.3
Cintron, V.J.4
Qiang, X.5
Goustin, A.S.6
Jen, K.L.7
Charron, M.J.8
Jahnen-Dechent, W.9
Grunberger, G.10
-
60
-
-
84859327136
-
Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes
-
Misu H, Ishikura K, Kurita S, Takeshita Y, Ota T, Saito Y, Takahashi K, Kaneko S, Takamura T (2012) Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One 7: e34952. http://dx.doi.org/10.1371/journal. pone.0034952.
-
(2012)
PLoS One
, vol.7
-
-
Misu, H.1
Ishikura, K.2
Kurita, S.3
Takeshita, Y.4
Ota, T.5
Saito, Y.6
Takahashi, K.7
Kaneko, S.8
Takamura, T.9
-
61
-
-
78049428301
-
A liver-derived secretory protein, selenoprotein P, causes insulin resistance
-
Misu H, Takamura T, Takayama H, Hayashi H, Matsuzawa-Nagata N, Kurita S, Ishikura K, Ando H, Takeshita Y, Ota T, Sakurai M, Yamashita T, Mizukoshi E, Yamashita T, Honda M, Miyamoto K, Kubota T, Kubota N, Kadowaki T, Kim HJ, Lee IK, Minokoshi Y, Saito Y, Takahashi K, Yamada Y, Takakura N, Kaneko S (2010) A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 12: 483-495. http://dx.doi.org/10.1016/j. cmet.2010.09.015.
-
(2010)
Cell Metab
, vol.12
, pp. 483-495
-
-
Misu, H.1
Takamura, T.2
Takayama, H.3
Hayashi, H.4
Matsuzawa-Nagata, N.5
Kurita, S.6
Ishikura, K.7
Ando, H.8
Takeshita, Y.9
Ota, T.10
Sakurai, M.11
Yamashita, T.12
Mizukoshi, E.13
Yamashita, T.14
Honda, M.15
Miyamoto, K.16
Kubota, T.17
Kubota, N.18
Kadowaki, T.19
Kim, H.J.20
Lee, I.K.21
Minokoshi, Y.22
Saito, Y.23
Takahashi, K.24
Yamada, Y.25
Takakura, N.26
Kaneko, S.27
more..
-
62
-
-
84855302030
-
Fetuin A and the cardiovascular system
-
Mori K, Emoto M, Inaba M (2012) Fetuin A and the cardiovascular system. Adv Clin Chem 56: 175-195. http://dx.doi.org/10.1016/B978-0-12-394317-0.00010-8.
-
(2012)
Adv Clin Chem
, vol.56
, pp. 175-195
-
-
Mori, K.1
Emoto, M.2
Inaba, M.3
-
64
-
-
33646367662
-
Association of serum fetuin-A with insulin resistance in type-2 diabetic and nondiabetic subject
-
Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y (2006) Association of serum fetuin-A with insulin resistance in type-2 diabetic and nondiabetic subject. Diabetes Care 29: 468. http://dx.doi.org/10.2337/diacare. 29.02.06.dc05-1484.
-
(2006)
Diabetes Care
, vol.29
, pp. 468
-
-
Mori, K.1
Emoto, M.2
Yokoyama, H.3
Araki, T.4
Teramura, M.5
Koyama, H.6
Shoji, T.7
Inaba, M.8
Nishizawa, Y.9
-
65
-
-
84863011453
-
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents
-
Mu J, Pinkstaff J, Li Z, Skidmore L, Li H, Myler H, Dallas-Yang Q, Putnam AM, Yao J, Bussell S, Wu M, Norman TC, Rodriquez CG, Kimmel B, Metzger JM, Manibusan A, Lee D, Zaller DM, Zhang BB, Dimarchi RD, Berger JP, Axelrod DW (2012) FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents. Diabetes 61: 505-512. http://dx.doi.org/10.2337/db11-0838.
-
(2012)
Diabetes
, vol.61
, pp. 505-512
-
-
Mu, J.1
Pinkstaff, J.2
Li, Z.3
Skidmore, L.4
Li, H.5
Myler, H.6
Dallas-Yang, Q.7
Putnam, A.M.8
Yao, J.9
Bussell, S.10
Wu, M.11
Norman, T.C.12
Rodriquez, C.G.13
Kimmel, B.14
Metzger, J.M.15
Manibusan, A.16
Lee, D.17
Zaller, D.M.18
Zhang, B.B.19
Dimarchi, R.D.20
Berger, J.P.21
Axelrod, D.W.22
more..
-
66
-
-
79952993729
-
Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome
-
Namkung J, Koh SB, Kong ID, Choi J-W, Yeh B-I (2011) Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism 60: 564-568. http://dx.doi.org/10.1016/j.metabol. 2010.05.013.
-
(2011)
Metabolism
, vol.60
, pp. 564-568
-
-
Namkung, J.1
Koh, S.B.2
Kong, I.D.3
Choi, J.-W.4
Yeh, B.-I.5
-
67
-
-
0034697846
-
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
-
Nishimura T, Nakatake Y, Konishi M, Itoh N (2000) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492: 203-206. http://dx.doi.org/10.1016/S0167-4781(00)00067-1.
-
(2000)
Biochim Biophys Acta
, vol.1492
, pp. 203-206
-
-
Nishimura, T.1
Nakatake, Y.2
Konishi, M.3
Itoh, N.4
-
68
-
-
20244380182
-
Angiopoietin-related growth factor antagonized obesity and insulin resistance
-
Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, Urano T, Kimura Y, Kubota Y, Maekawa H, Miyamoto T, Miyata K, Matsumoto S, Sakai J, Nakagata N, Takeya M, Koseki H, Ogawa Y, Kadowaki T, Suda T (2005) Angiopoietin-related growth factor antagonized obesity and insulin resistance. Nat Med 11: 400-408. http://dx.doi.org/10.1038/nm1214.
-
(2005)
Nat Med
, vol.11
, pp. 400-408
-
-
Oike, Y.1
Akao, M.2
Yasunaga, K.3
Yamauchi, T.4
Morisada, T.5
Ito, Y.6
Urano, T.7
Kimura, Y.8
Kubota, Y.9
Maekawa, H.10
Miyamoto, T.11
Miyata, K.12
Matsumoto, S.13
Sakai, J.14
Nakagata, N.15
Takeya, M.16
Koseki, H.17
Ogawa, Y.18
Kadowaki, T.19
Suda, T.20
more..
-
69
-
-
0042925274
-
Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling and regeneration
-
Oike Y, Kasunaga K, Ito Y, Matsumoto S, Maekawa H, Morisada T, Arai F, Nakagata N, Takeya M, Masuho Y, Suda T (2003) Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling and regeneration. Proc Natl Acad Sci USA 100: 9494-9499. http://dx.doi.org/10.1073/pnas.1531901100.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 9494-9499
-
-
Oike, Y.1
Kasunaga, K.2
Ito, Y.3
Matsumoto, S.4
Maekawa, H.5
Morisada, T.6
Arai, F.7
Nakagata, N.8
Takeya, M.9
Masuho, Y.10
Suda, T.11
-
70
-
-
84892732372
-
Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) in obesity and fatty liver
-
Okumura A, Unoki-Kubota H, Matsushita Y, Shiga T, Moriyoshi Y, Yamagoe S, Kaburagi Y (2013) Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) in obesity and fatty liver. Biosci Trends 7: 276-283. http://dx.doi.org/10.5582/bst.2013.v7.6.276.
-
(2013)
Biosci Trends
, vol.7
, pp. 276-283
-
-
Okumura, A.1
Unoki-Kubota, H.2
Matsushita, Y.3
Shiga, T.4
Moriyoshi, Y.5
Yamagoe, S.6
Kaburagi, Y.7
-
71
-
-
0037148928
-
Leptin-replacement therapy for lipodystrophy
-
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346: 570-578. http://dx.doi.org/10.1056/NEJMoa012437.
-
(2002)
N Engl J Med
, vol.346
, pp. 570-578
-
-
Oral, E.A.1
Simha, V.2
Ruiz, E.3
Andewelt, A.4
Premkumar, A.5
Snell, P.6
Wagner, A.J.7
DePaoli, A.M.8
Reitman, M.L.9
Taylor, S.I.10
Gorden, P.11
Garg, A.12
-
72
-
-
84870736698
-
Increased fetuin-A concentration in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose
-
Ou H-Y, Yang Y-C, Wu H-T, Wu J-S, Lu F-H, Chang C-J (2012) Increased fetuin-A concentration in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J Clin Endocrinol Metab 97: 4717-4723. http://dx.doi. org/10.1210/jc.2012-2414.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 4717-4723
-
-
Ou, H.-Y.1
Yang, Y.-C.2
Wu, H.-T.3
Wu, J.-S.4
Lu, F.-H.5
Chang, C.-J.6
-
73
-
-
79961058891
-
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk
-
Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C (2011) Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 17: 3082-3091. http://dx.doi. org/10.3748/wjg.v17.i26.3082.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 3082-3091
-
-
Pacifico, L.1
Nobili, V.2
Anania, C.3
Verdecchia, P.4
Chiesa, C.5
-
74
-
-
84864657351
-
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
-
Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18: 1279-1285. http://dx.doi.org/10.1038/nm.2851.
-
(2012)
Nat Med
, vol.18
, pp. 1279-1285
-
-
Pal, D.1
Dasgupta, S.2
Kundu, R.3
Maitra, S.4
Das, G.5
Mukhopadhyay, S.6
Ray, S.7
Majumdar, S.S.8
Bhattacharya, S.9
-
75
-
-
79954558287
-
Adipokines and redox signaling: impact on fatty liver disease
-
Parola M, Marra F (2011) Adipokines and redox signaling: impact on fatty liver disease. Antioxid Redox Signal 15: 461-483. http://dx.doi. org/10.1089/ars.2010.3848.
-
(2011)
Antioxid Redox Signal
, vol.15
, pp. 461-483
-
-
Parola, M.1
Marra, F.2
-
76
-
-
0001513835
-
Fetuin, a new globulin isolated from serum
-
Pedersen KO (1944). Fetuin, a new globulin isolated from serum. Nature 154: 575. http://dx.doi.org/10.1038/154575a0.
-
(1944)
Nature
, vol.154
, pp. 575
-
-
Pedersen, K.O.1
-
77
-
-
84901944641
-
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
-
Perry RJ, Samuel VT, Petersen KF, Shulman GI (2014) The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510: 84-91. http://dx.doi.org/10.1038/nature13478.
-
(2014)
Nature
, vol.510
, pp. 84-91
-
-
Perry, R.J.1
Samuel, V.T.2
Petersen, K.F.3
Shulman, G.I.4
-
78
-
-
78650042692
-
Relationship of circulation sex-hormone-binding globulin with metabolic traits in humans
-
Peter A, Kantartzis K, Machann J, Schick F, Staiger H, Machicao F, Schleicher E, Fritsche A, Haring H-U, Stefan N (2010) Relationship of circulation sex-hormone-binding globulin with metabolic traits in humans. Diabetes 59: 3167-3173. http://dx.doi.org/10.2337/db10-0179.
-
(2010)
Diabetes
, vol.59
, pp. 3167-3173
-
-
Peter, A.1
Kantartzis, K.2
Machann, J.3
Schick, F.4
Staiger, H.5
Machicao, F.6
Schleicher, E.7
Fritsche, A.8
Haring, H.-U.9
Stefan, N.10
-
79
-
-
84862193848
-
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
-
Peter A, Kantartzis K, Machicao F, Machann J, Wagner S, Templin S, Konigsrainer I, Konigsrainer A, Schick F, Fritsche A, Haring H-U, Stefan N (2012) Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content. Int J Obes (Lond) 36: 774-782. http://dx.doi.org/10.1038/ijo.2011.154.
-
(2012)
Int J Obes (Lond)
, vol.36
, pp. 774-782
-
-
Peter, A.1
Kantartzis, K.2
Machicao, F.3
Machann, J.4
Wagner, S.5
Templin, S.6
Konigsrainer, I.7
Konigsrainer, A.8
Schick, F.9
Fritsche, A.10
Haring, H.-U.11
Stefan, N.12
-
80
-
-
77950202777
-
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
-
Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, Dziura J, Lifton RP, Shulman GI (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362: 1082-1089. http://dx.doi.org/10.1056/NEJMoa0907295.
-
(2010)
N Engl J Med
, vol.362
, pp. 1082-1089
-
-
Petersen, K.F.1
Dufour, S.2
Hariri, A.3
Nelson-Williams, C.4
Foo, J.N.5
Zhang, X.M.6
Dziura, J.7
Lifton, R.P.8
Shulman, G.I.9
-
81
-
-
84885218849
-
Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease
-
Polyzos SA, Kountouras J, Tsatsoulis A, Zafeiriadou E, Katsiki E, Patsiaoura K, Zavos C, Anastasiadou VV, Slavakis A (2013) Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease. Hormones (Athens) 12: 405-416.
-
(2013)
Hormones (Athens)
, vol.12
, pp. 405-416
-
-
Polyzos, S.A.1
Kountouras, J.2
Tsatsoulis, A.3
Zafeiriadou, E.4
Katsiki, E.5
Patsiaoura, K.6
Zavos, C.7
Anastasiadou, V.V.8
Slavakis, A.9
-
82
-
-
80052538157
-
Time-dependent effect of Prkce deletion on glucose hemostasis and hepatic lipid metabolism on dietary liver oversupplay in mice
-
Raddatz K, Turner N, Frangioudakis G, Liao BM, Pedersen DJ, Cantley J, Wilks D, Preston E, Hegarty BD, Leitges M, Raftery MJ, Biden TJ, Schmitz-Peiffer C (2011) Time-dependent effect of Prkce deletion on glucose hemostasis and hepatic lipid metabolism on dietary liver oversupplay in mice. Diabetologia 54: 1447-1456. http://dx.doi.org/10.1007/s00125-011-2073-0.
-
(2011)
Diabetologia
, vol.54
, pp. 1447-1456
-
-
Raddatz, K.1
Turner, N.2
Frangioudakis, G.3
Liao, B.M.4
Pedersen, D.J.5
Cantley, J.6
Wilks, D.7
Preston, E.8
Hegarty, B.D.9
Leitges, M.10
Raftery, M.J.11
Biden, T.J.12
Schmitz-Peiffer, C.13
-
83
-
-
57349109502
-
Fetuin A and its relations to metabolic syndrome and fatty liver disease in obese children before and after weight loss
-
Reinehr T, Roth CL (2008) Fetuin A and its relations to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93: 4479-4485. http://dx.doi. org/10.1210/jc.2008-1505.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 4479-4485
-
-
Reinehr, T.1
Roth, C.L.2
-
84
-
-
84861996283
-
Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis
-
Reinehr T, Woelfle J, Wunsch R, Roth CL (2012) Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab 97: 2143-2150. http://dx.doi.org/10.1210/jc.2012-1221.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2143-2150
-
-
Reinehr, T.1
Woelfle, J.2
Wunsch, R.3
Roth, C.L.4
-
85
-
-
84879295847
-
Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise
-
Reschke S, Eckel J (2013) Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm 2013: 320724. http://dx.doi.org/10.1155/2013/320724.
-
(2013)
Mediators Inflamm
, vol.2013
-
-
Reschke, S.1
Eckel, J.2
-
86
-
-
33745107554
-
Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance
-
Roden (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 6: 335-348. http://dx.doi.org/10.1038/ncpendmet0190.
-
(2006)
Nat Clin Pract Endocrinol Metab
, vol.6
, pp. 335-348
-
-
Roden1
-
87
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Gen 40: 1461-1465. http://dx.doi.org/10.1038/ng.257.
-
(2008)
Nat Gen
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
Pertsemlidis, A.4
Cox, D.5
Pennacchio, L.A.6
Boerwinkle, E.7
Cohen, J.C.8
Hobbs, H.H.9
-
88
-
-
77953122859
-
Serum fetuin A, cardiovascular risk factor, and six-year follow-up outcome in patients with coronary heart disease
-
Roos M, von Eynatten M, Heemann U, Rothenbacher D, Brenner H, Breitling LP (2010) Serum fetuin A, cardiovascular risk factor, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 105: 1666-1672. http://dx.doi.org/10.1016/j.amjcard. 2010.01.342.
-
(2010)
Am J Cardiol
, vol.105
, pp. 1666-1672
-
-
Roos, M.1
von Eynatten, M.2
Heemann, U.3
Rothenbacher, D.4
Brenner, H.5
Breitling, L.P.6
-
89
-
-
3543029821
-
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
-
Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279: 32345-32353. http://dx.doi.org/10.1074/jbc.M313478200.
-
(2004)
J Biol Chem
, vol.279
, pp. 32345-32353
-
-
Samuel, V.T.1
Liu, Z.X.2
Qu, X.3
Elder, B.D.4
Bilz, S.5
Befroy, D.6
Romanelli, A.J.7
Shulman, G.I.8
-
90
-
-
84922746132
-
Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects
-
Sato M, Kamada Y, Takeda Y, Kida S, Ohara Y, Fujii H, Akita M, Mizutani K, Yoshida Y, Yamada M, Hougaku H, Takehara T, Miyoshi E (2015) Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects. Liver Int 35: 925-935. http://dx.doi.org/10.1111/liv.12478.
-
(2015)
Liver Int
, vol.35
, pp. 925-935
-
-
Sato, M.1
Kamada, Y.2
Takeda, Y.3
Kida, S.4
Ohara, Y.5
Fujii, H.6
Akita, M.7
Mizutani, K.8
Yoshida, Y.9
Yamada, M.10
Hougaku, H.11
Takehara, T.12
Miyoshi, E.13
-
91
-
-
84862795311
-
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
-
Shen J, Chan HL, Wong GL, Choi PC, Chan AW, Chan HY, Chim AM, Yeung DK, Chan FK, Woo J, Yu J, Chu WC, Wong VW (2012) Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J Hepatol 56: 1363-1370. http://dx.doi.org/10.1016/j.jhep.2011.12.025.
-
(2012)
J Hepatol
, vol.56
, pp. 1363-1370
-
-
Shen, J.1
Chan, H.L.2
Wong, G.L.3
Choi, P.C.4
Chan, A.W.5
Chan, H.Y.6
Chim, A.M.7
Yeung, D.K.8
Chan, F.K.9
Woo, J.10
Yu, J.11
Chu, W.C.12
Wong, V.W.13
-
92
-
-
80054888593
-
Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes
-
Shin JY, Kim S-K, Lee MY, Kim HS, Ye BI, Shin YG, Baik SK, Chung CH (2011) Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. Diabetes Res Clin Pract 94: 156-162. http://dx.doi.org/10.1016/j.diabres.2011.07.029.
-
(2011)
Diabetes Res Clin Pract
, vol.94
, pp. 156-162
-
-
Shin, J.Y.1
Kim, S.-K.2
Lee, M.Y.3
Kim, H.S.4
Ye, B.I.5
Shin, Y.G.6
Baik, S.K.7
Chung, C.H.8
-
93
-
-
23644433509
-
A synonymous coding polymorphism in the a2-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French Caucasian
-
Siddiq A, Lepretre F, Hercberg S, Froguel P, Gibson F (2005) A synonymous coding polymorphism in the a2-Heremans-Schmid glycoprotein gene is associated with type 2 diabetes in French Caucasian. Diabetes 54: 2477-2481. http://dx.doi.org/10.2337/diabetes. 54.8.2477.
-
(2005)
Diabetes
, vol.54
, pp. 2477-2481
-
-
Siddiq, A.1
Lepretre, F.2
Hercberg, S.3
Froguel, P.4
Gibson, F.5
-
94
-
-
84905020685
-
Adiponectin upregulates SHGB production: molecular mechanisms and potential implication
-
Simo R, Saez-Lopez C, Lecube A, Hernandez C, Fort JM, Selva DM (2014) Adiponectin upregulates SHGB production: molecular mechanisms and potential implication. Endocrinology 155: 2820-2830. http://dx.doi.org/10.1210/en.2014-1072.
-
(2014)
Endocrinology
, vol.155
, pp. 2820-2830
-
-
Simo, R.1
Saez-Lopez, C.2
Lecube, A.3
Hernandez, C.4
Fort, J.M.5
Selva, D.M.6
-
95
-
-
84937518300
-
Novel insights in SHGB regulation and clinical Implication
-
Simo R, Saez-Lopez C, Lecube A, Hernandez C, Fort JM, Selva DM (2015) Novel insights in SHGB regulation and clinical Implication. Trends Endocrinol Metab 26: 376-383. http://dx.doi.org/10.1016/j. tem.2015.05.001.
-
(2015)
Trends Endocrinol Metab
, vol.26
, pp. 376-383
-
-
Simo, R.1
Saez-Lopez, C.2
Lecube, A.3
Hernandez, C.4
Fort, J.M.5
Selva, D.M.6
-
96
-
-
0027333427
-
Serum a2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level
-
Srinivas PR, Wagner AS, Reddy LU, Deutsch DD, Leon MA, Goustin AS, Grunberger G (1993) Serum a2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7: 1445-1455. http://dx.doi.org/10.1210/mend.7.11.7906861.
-
(1993)
Mol Endocrinol
, vol.7
, pp. 1445-1455
-
-
Srinivas, P.R.1
Wagner, A.S.2
Reddy, L.U.3
Deutsch, D.D.4
Leon, M.A.5
Goustin, A.S.6
Grunberger, G.7
-
97
-
-
84875549943
-
The role of hepatokines in metabolism
-
Stefan N, Haring H-U (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol 9: 144-152. http://dx.doi.org/10.1038/nrendo. 2012.258.
-
(2013)
Nat Rev Endocrinol
, vol.9
, pp. 144-152
-
-
Stefan, N.1
Haring, H.-U.2
-
98
-
-
84878433548
-
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans
-
Stefan N, Haring H-U (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med 19: 394-395. http://dx.doi.org/10.1038/nm.3116.
-
(2013)
Nat Med
, vol.19
, pp. 394-395
-
-
Stefan, N.1
Haring, H.-U.2
-
99
-
-
33746367157
-
Alpha2-Heremans-Schmid glycoprotein/fetuin A is associated with insulin resistance and fat accumulation in the liver in humans
-
Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, Machicao F, Fritsche A, Haring H-U (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29: 853-857. http://dx.doi.org/10.2337/diacare.29.04.06.dc05-1938.
-
(2006)
Diabetes Care
, vol.29
, pp. 853-857
-
-
Stefan, N.1
Hennige, A.M.2
Staiger, H.3
Machann, J.4
Schick, F.5
Krober, S.M.6
Machicao, F.7
Fritsche, A.8
Haring, H.-U.9
-
100
-
-
57349116780
-
Causes and metabolic consequences of fatty liver
-
Stefan N, Kantartzis K, Haring H-U (2008) Causes and metabolic consequences of fatty liver. Endocr Rev 29: 939-960. http://dx.doi. org/10.1210/er.2008-0009.
-
(2008)
Endocr Rev
, vol.29
, pp. 939-960
-
-
Stefan, N.1
Kantartzis, K.2
Haring, H.-U.3
-
101
-
-
74049133977
-
Sex hormone-binding globulin and risk of type 2 diabetes
-
Stefan N, Schick F, Haring H-U (2009) Sex hormone-binding globulin and risk of type 2 diabetes. N Eng J Med 361: 2675-2676. http://dx.doi.org/10.1056/NEJMc0910143.
-
(2009)
N Eng J Med
, vol.361
, pp. 2675-2676
-
-
Stefan, N.1
Schick, F.2
Haring, H.-U.3
-
102
-
-
84918819322
-
Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease
-
Stefan N, Schick F, Haring H-U (2014) Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N End J Med 371: 2236-2237. http://dx.doi.org/10.1056/NEJMc 1412427#SA3.
-
(2014)
N End J Med
, vol.371
, pp. 2236-2237
-
-
Stefan, N.1
Schick, F.2
Haring, H.-U.3
-
103
-
-
84898670730
-
Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort-and cross-sectional phenotyping studies
-
Stefan N, Sun Q, Fritsche A, Machann J, Schick F, Gerst F, Jeppesen C, Joost HG, Hu FB, Boeing H, Ullrich S, Häring HU, Schulze MB (2014) Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort-and cross-sectional phenotyping studies. PLoS One 18: e92238. http://dx.doi.org/10.1371/journal.pone.0092238.
-
(2014)
PLoS One
, vol.18
-
-
Stefan, N.1
Sun, Q.2
Fritsche, A.3
Machann, J.4
Schick, F.5
Gerst, F.6
Jeppesen, C.7
Joost, H.G.8
Hu, F.B.9
Boeing, H.10
Ullrich, S.11
Häring, H.U.12
Schulze, M.B.13
-
104
-
-
20144365466
-
Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factor in multiethnic premenopausal and perimenopausel women enrolled in the Study of Women Across the Nation (SWAN)
-
Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torrens JL, SWAN investigators (2005) Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factor in multiethnic premenopausal and perimenopausel women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111: 1242-1249. http://dx.doi.org/10.1161/01.CIR.0000157697.54255.CE.
-
(2005)
Circulation
, vol.111
, pp. 1242-1249
-
-
Sutton-Tyrrell, K.1
Wildman, R.P.2
Matthews, K.A.3
Chae, C.4
Lasley, B.L.5
Brockwell, S.6
Pasternak, R.C.7
Lloyd-Jones, D.8
Sowers, M.F.9
Torrens, J.L.10
-
105
-
-
73249130996
-
High glucose induces transactivation of the a2-HS glycoprotein gene through the ERK1/2 signaling pathway
-
Takata H, Ikeda Y, Suehiro T, Ishibashi A, Inoue M, Kumon Y, Terada Y (2009) High glucose induces transactivation of the a2-HS glycoprotein gene through the ERK1/2 signaling pathway. J Atheroscler Thromb 16: 448-456. http://dx.doi.org/10.5551/jat.No950.
-
(2009)
J Atheroscler Thromb
, vol.16
, pp. 448-456
-
-
Takata, H.1
Ikeda, Y.2
Suehiro, T.3
Ishibashi, A.4
Inoue, M.5
Kumon, Y.6
Terada, Y.7
-
106
-
-
84925778793
-
Role of fibroblast growth factor 21 in early stage of NASH induced by methionine-and choline-deficient diet
-
Tanaka N, Takahashi S, Zhang Y, Krausz KW, Smith PB, Patterson AD, Gonzalez FJ (2015) Role of fibroblast growth factor 21 in early stage of NASH induced by methionine-and choline-deficient diet. Biochim Biophys Acta 1852: 1242-1252. http://dx.doi.org/10.1016/j. bbadis.2015.02.012.
-
(2015)
Biochim Biophys Acta
, vol.1852
, pp. 1242-1252
-
-
Tanaka, N.1
Takahashi, S.2
Zhang, Y.3
Krausz, K.W.4
Smith, P.B.5
Patterson, A.D.6
Gonzalez, F.J.7
-
107
-
-
33644700376
-
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
-
Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G (2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54: 3541-3546. http://dx.doi.org/10.2337/diabetes.54.12.3541.
-
(2005)
Diabetes
, vol.54
, pp. 3541-3546
-
-
Targher, G.1
Bertolini, L.2
Poli, F.3
Rodella, S.4
Scala, L.5
Tessari, R.6
Zenari, L.7
Falezza, G.8
-
108
-
-
77957375969
-
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
-
Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Eng J Med 363: 1341-1350. http://dx.doi.org/10.1056/NEJMra0912063.
-
(2010)
N Eng J Med
, vol.363
, pp. 1341-1350
-
-
Targher, G.1
Day, C.P.2
Bonora, E.3
-
109
-
-
79960029926
-
Systematic review: the epidemiology and natural history on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34: 274-285. http://dx.doi.org/10.1111/j.1365-2036.2011.04724.x.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
110
-
-
58149393662
-
Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke
-
Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A (2008) Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 118: 2555-2562. http://dx.doi.org/10.1161/CIRCULATIONAHA. 108.814418.
-
(2008)
Circulation
, vol.118
, pp. 2555-2562
-
-
Weikert, C.1
Stefan, N.2
Schulze, M.B.3
Pischon, T.4
Berger, K.5
Joost, H.G.6
Haring, H.U.7
Boeing, H.8
Fritsche, A.9
-
111
-
-
61649127208
-
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice
-
Xu J, Lloyd DJ, Hale C. Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK, Veniant MM (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58: 250-259. http://dx.doi.org/10.2337/db08-0392.
-
(2009)
Diabetes
, vol.58
, pp. 250-259
-
-
Xu, J.1
Lloyd, D.J.2
Hale, C.3
Stanislaus, S.4
Chen, M.5
Sivits, G.6
Vonderfecht, S.7
Hecht, R.8
Li, Y.S.9
Lindberg, R.A.10
Chen, J.L.11
Jung, D.Y.12
Zhang, Z.13
Ko, H.J.14
Kim, J.K.15
Veniant, M.M.16
-
112
-
-
0030217827
-
Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2
-
Yamagoe S, Yamakawa Y, Matsuo Y, Minowada J, Mizuno S, Suzuki K (1996) Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett 52: 9-13. http://dx.doi.org/10.1016/0165-2478(96)02572-2.
-
(1996)
Immunol Lett
, vol.52
, pp. 9-13
-
-
Yamagoe, S.1
Yamakawa, Y.2
Matsuo, Y.3
Minowada, J.4
Mizuno, S.5
Suzuki, K.6
-
113
-
-
0032481611
-
Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liver
-
Yamagoe S, Mizuno S, Suzuki K (1998) Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liver. Biochem Biophys Acta 1396: 105-113. http://dx.doi.org/10.1016/S0167-4781(97)00181-4.
-
(1998)
Biochem Biophys Acta
, vol.1396
, pp. 105-113
-
-
Yamagoe, S.1
Mizuno, S.2
Suzuki, K.3
-
114
-
-
80052845230
-
Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content
-
Yan H, Xia M, Chang X, Xu Q, Bian H, Zeng M, Rao S, Yao X, Tu Y, Jia W, Gao X (2011) Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content. PLoS One 6: e24895. http://dx.doi.org/10.1371/journal.pone.0024895.
-
(2011)
PLoS One
, vol.6
-
-
Yan, H.1
Xia, M.2
Chang, X.3
Xu, Q.4
Bian, H.5
Zeng, M.6
Rao, S.7
Yao, X.8
Tu, Y.9
Jia, W.10
Gao, X.11
-
115
-
-
79961235988
-
Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis
-
Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2011) Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab 96: 1325-1329. http://dx.doi.org/10.1210/jc.2011-0620.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 1325-1329
-
-
Yang, S.J.1
Hwang, S.Y.2
Choi, H.Y.3
Yoo, H.J.4
Seo, J.A.5
Kim, S.G.6
Kim, N.H.7
Baik, S.H.8
Choi, D.S.9
Choi, K.M.10
-
116
-
-
77956519052
-
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
-
Yilmaz Y, Eren F, Yonal O, Kuty R, Altas B, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E (2010) Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. Eur J Clin Invest 40: 887-892. http://dx.doi.org/10.1111/j.1365-2362.2010.02338.x.
-
(2010)
Eur J Clin Invest
, vol.40
, pp. 887-892
-
-
Yilmaz, Y.1
Eren, F.2
Yonal, O.3
Kuty, R.4
Altas, B.5
Celikel, C.A.6
Ozdogan, O.7
Imeryuz, N.8
Kalayci, C.9
Avsar, E.10
-
117
-
-
78449301931
-
Serum fetuin A/alpha2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
-
Yilmaz Y, Yonal O, Kurt R, Ari F, Oral AY, Celikel CA, Korkmaz S, Ulukaya E, Ozdogan O, Imeryuz N, Avsar E, Kalayci C (2010) Serum fetuin A/alpha2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Ann Clin Biochem 47: 549-553. http://dx.doi.org/10.1258/acb.2010.010169.
-
(2010)
Ann Clin Biochem
, vol.47
, pp. 549-553
-
-
Yilmaz, Y.1
Yonal, O.2
Kurt, R.3
Ari, F.4
Oral, A.Y.5
Celikel, C.A.6
Korkmaz, S.7
Ulukaya, E.8
Ozdogan, O.9
Imeryuz, N.10
Avsar, E.11
Kalayci, C.12
-
118
-
-
84923239473
-
Hepatokines as a link between obesity and cardiovascular disease
-
Yoo HJ, Choi KM (2015) Hepatokines as a link between obesity and cardiovascular disease. Diabetes Metab J 39: 10-15. http://dx.doi. org/10.4093/dmj.2015.39.1.10.
-
(2015)
Diabetes Metab J
, vol.39
, pp. 10-15
-
-
Yoo, H.J.1
Choi, K.M.2
-
119
-
-
0037184925
-
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in the muscle
-
Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in the muscle. J Biol Chem 277: 50230-50236. http://dx.doi.org/10.1074/jbc.M200958200.
-
(2002)
J Biol Chem
, vol.277
, pp. 50230-50236
-
-
Yu, C.1
Chen, Y.2
Cline, G.W.3
Zhang, D.4
Zong, H.5
Wang, Y.6
Bergeron, R.7
Kim, J.K.8
Cushman, S.W.9
Cooney, G.J.10
Atcheson, B.11
White, M.F.12
Kraegen, E.W.13
Shulman, G.I.14
-
120
-
-
79960844094
-
The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes
-
Zhang Y, Lei T, Huang JF, Wang SB, Zhou LL, Yang ZQ, Chen XD (2011) The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes. Mol Cell Endocrinol 342: 41-47. http://dx.doi.org/10.1016/j. mce.2011.05.003.
-
(2011)
Mol Cell Endocrinol
, vol.342
, pp. 41-47
-
-
Zhang, Y.1
Lei, T.2
Huang, J.F.3
Wang, S.B.4
Zhou, L.L.5
Yang, Z.Q.6
Chen, X.D.7
-
121
-
-
84949776698
-
Fibroblast growth factor 21 analogs for treating metabolic disorders
-
Zhang Y, Lei T (2015) Fibroblast growth factor 21 analogs for treating metabolic disorders. Front Endocrinol (Laussanne) 8: 168. http://dx.doi.org/10.3389/fendo.2015.00168.
-
(2015)
Front Endocrinol (Laussanne)
, vol.8
, pp. 168
-
-
Zhang, Y.1
Lei, T.2
|